International Myeloma Working Group Consensus Statement for the Management, Treatment, and Supportive Care of Patients With Myeloma Not Eligible for Standard Autologous Stem-Cell Transplantation
Antonio Palumbo(Azienda Ospedaliero Universitaria San Giovanni Battista), Robert Z. Orlowski(University of North Carolina at Chapel Hill), Hermann Einsele(University of Würzburg), Jesús F. San Miguel(Universidad de Salamanca), Sagar Lonial(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Alessandra Larocca(Cornell University), Brian G.M. Durie(Spanish Head & Neck Cancer Cooperative Group), Kenneth C. Anderson(Novartis (Switzerland)), Meletios Α. Dimopoulos(National and Kapodistrian University of Athens), Paul G. Richardson(Dana-Farber Cancer Institute), S. Vincent Rajkumar(Mayo Clinic), Michèle Cavo(University of Bologna), Rubén Niesvizky(Cornell University), Ola Landgren(Cornell University), Roman Hájek(University Hospital Brno), Gareth J. Morgan(NYU Langone Health), Kazuyuki Shimizu(Spanish Head & Neck Cancer Cooperative Group), Philippe Moreau(Institut Paoli-Calmettes), Andrew Spencer(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), A. Keith Stewart(Mayo Clinic), Pieter Sonneveld(Erasmus MC Cancer Institute)
Cited by 384
Related Papers
The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report
|The Lancet|2019|3k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k